Charles Schwab Investment Management Inc. Acquires 28,015 Shares of 908 Devices Inc. (NASDAQ:MASS)

Charles Schwab Investment Management Inc. boosted its holdings in 908 Devices Inc. (NASDAQ:MASS) by 14.6% in the 3rd quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 220,477 shares of the company’s stock after purchasing an additional 28,015 shares during the period. Charles Schwab Investment Management Inc. owned approximately 0.64% of 908 Devices worth $765,000 at the end of the most recent reporting period.

Several other institutional investors have also added to or reduced their stakes in MASS. Connor Clark & Lunn Investment Management Ltd. bought a new stake in 908 Devices in the third quarter valued at approximately $190,000. Drive Wealth Management LLC purchased a new position in shares of 908 Devices in the third quarter worth $50,000. SG Americas Securities LLC bought a new stake in 908 Devices during the 3rd quarter valued at $36,000. Cubist Systematic Strategies LLC purchased a new stake in 908 Devices during the 2nd quarter valued at $311,000. Finally, Millennium Management LLC grew its holdings in 908 Devices by 35.5% in the 2nd quarter. Millennium Management LLC now owns 618,310 shares of the company’s stock worth $3,184,000 after acquiring an additional 161,922 shares during the last quarter. 88.06% of the stock is currently owned by hedge funds and other institutional investors.

Analysts Set New Price Targets

A number of research analysts recently issued reports on the company. Leerink Partners restated a “market perform” rating and set a $4.00 price target (down previously from $12.00) on shares of 908 Devices in a report on Wednesday, November 13th. Leerink Partnrs cut 908 Devices from a “strong-buy” rating to a “hold” rating in a research note on Wednesday, November 13th. Finally, Stifel Nicolaus dropped their price target on 908 Devices from $17.00 to $6.00 and set a “buy” rating for the company in a research note on Wednesday, November 13th.

908 Devices Price Performance

NASDAQ:MASS opened at $1.88 on Thursday. 908 Devices Inc. has a 1-year low of $1.82 and a 1-year high of $12.51. The company has a market capitalization of $65.47 million, a PE ratio of -1.06 and a beta of 0.92. The firm’s 50-day moving average price is $2.91 and its 200-day moving average price is $4.03.

908 Devices Profile

908 Devices Inc, a commercial-stage technology company, provides various purpose-built handheld and desktop mass spectrometry devices to interrogate unknown and invisible materials in life sciences research, bioprocessing, pharma/biopharma, forensics, and adjacent markets. The company's products include MX908, a handheld, battery-powered, and Mass Spec device that is designed for rapid analysis of solid, liquid, vapor, and aerosol materials of unknown identity; Rebel, a small desktop analyzer that provides real-time information on the extracellular environment in bioprocesses; and Maverick, an optical in-line analyzer that offers real-time monitoring and control of multiple bioprocess parameters, including glucose, lactate, and total biomass in mammalian cell cultures, as well as provides process fingerprint data to support large-scale efforts in predictive bioprocess modeling.